Linezolid and Glucose Injection 100ml: 0.2g / High Quality

• Customization: Available
• Packing: Customization
• Materials: PP
• Model NO.: injection
• Transport Package: Carton
• Specification: 100ml: 0.2g
• Trademark: Sinolead
• Origin: China

Product Description

Value-added services:
 Packaging design by our team
 Registration service by our team
 Registration dossier available by our team
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
 

Linezolid and Glucose Injection 100ml:0.2g

Composition:

Each 100ml contains:

• Linezolid 0.2g (200mg)
• Glucose (sufficient quantity)

Description:

Linezolid is an oxazolidinone-class antibiotic with activity against Gram-positive bacteria, including resistant strains like methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). The glucose component provides necessary caloric intake for patients requiring parenteral nutrition support.

Indications:

Linezolid and Glucose Injection is indicated for the treatment of infections caused by susceptible Gram-positive bacteria, including:

• Nosocomial pneumonia (including MRSA-related pneumonia)
• Community-acquired pneumonia
• Complicated skin and soft tissue infections
• Vancomycin-resistant Enterococcus faecium (VRE) infections, including bacteremia

Dosage & Administration:

Adults & Adolescents (≥12 years):

• 600mg IV every 12 hours (infused over 30-120 minutes)
• Duration: 10-14 days, depending on infection severity

Pediatric Patients (<12 years):

• 10 mg/kg IV every 8 hours
• Duration: 10-14 days

Administration:

• Intravenous (IV) infusion only
• Administer over 30-120 minutes
• Do NOT mix with other IV medications
• No further dilution required

Contraindications:

• Hypersensitivity to Linezolid or any component of the formulation
• Patients using monoamine oxidase inhibitors (MAOIs) or within 2 weeks of MAOI use

Precautions:

• Myelosuppression (thrombocytopenia, anemia, leukopenia) - Monitor CBC weekly.
• Peripheral & optic neuropathy - Prolonged use may cause vision problems.
• Serotonin Syndrome Risk - Avoid with SSRIs, SNRIs, or other serotonergic drugs.
• Lactic Acidosis - Monitor for unexplained acidosis or low bicarbonate levels.
• Hyperglycemia risk - Caution in diabetic patients due to glucose content.

Adverse Reactions:

• Hematologic: Thrombocytopenia, anemia
• Neurologic: Headache, peripheral neuropathy
• Gastrointestinal: Nausea, vomiting, diarrhea
• Metabolic: Lactic acidosis, hyperglycemia
• Injection Site Reactions: Phlebitis, irritation

Drug Interactions:

• SSRIs, SNRIs, Tricyclic Antidepressants - Increased serotonin syndrome risk
• MAOIs (e.g., phenelzine, isocarboxazid) - Risk of hypertensive crisis
• Adrenergic agents (e.g., pseudoephedrine) - May enhance hypertensive effects
• Hypoglycemic agents (e.g., insulin) - Monitor blood glucose levels

Storage Conditions:

• Store below 25°C, protect from light.
• Do NOT freeze.
• Use within 24 hours after opening.

• •